Alterity Therapeutics (ATHE) Total Non-Current Liabilities (2009 - 2025)

Alterity Therapeutics (ATHE) recorded quarterly Total Non-Current Liabilities of $42980.1 in Q4 2025, down 24.21% quarter-over-quarter from $56707.2 in Q2 2025, and up 52.43% on a YoY basis from $28197.3 in Q4 2024.

Alterity Therapeutics (ATHE) Total Non-Current Liabilities (2009 - 2025) Analysis & Trends

Alterity Therapeutics' Total Non-Current Liabilities history runs 16 years deep, the most recent figure standing at $42980.1 for Q4 2025.

  • In Q4 2025, Total Non-Current Liabilities rose 52.43% year-over-year to $42980.1; the TTM figure through Dec 2025 stood at $42980.1 (up 52.43% YoY), while the FY2025 annual figure was $56707.2, up 104.93% from the prior year.
  • Total Non-Current Liabilities was $42980.1 for Q4 2025 at Alterity Therapeutics, down from $56707.2 in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $82014.5 in Q2 2023 to a low of $28197.3 in Q4 2024.
  • Historically, Total Non-Current Liabilities has averaged $44333.2 across 5 years, with a median of $39844.7 in 2025.
  • The sharpest annual moves came in 2021 and 2024: Total Non-Current Liabilities soared 388.34% in 2021, then slumped 58.28% in 2024.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $28873.4 in 2021, then climbed by 7.74% to $31108.7 in 2022, then soared by 60.1% to $49804.0 in 2023, then sank by 43.38% to $28197.3 in 2024, then jumped by 52.43% to $42980.1 in 2025.
  • The last three Total Non-Current Liabilities figures came in at $42980.1 (Q4 2025), $56707.2 (Q2 2025), and $28197.3 (Q4 2024), per Business Quant data.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 42,980.09
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 11.03 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 95.20 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 644,700.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 5.87 Bn
9 Abivax 91.96 Bn 91.96 Bn - 64.76 Mn
10 Regeneron Pharmaceuticals 63.43 Bn 54.67 Bn 3.31 Bn 7.32 Bn

Historic Data

Download Data
DateValue
Dec 31, 2025 42,980.09
Jun 30, 2025 56,707.16
Dec 31, 2024 28,197.30
Jun 30, 2024 34,212.60
Dec 31, 2023 49,804.03
Jun 30, 2023 82,014.51
Dec 31, 2022 31,108.67
Jun 30, 2022 52,724.51
Dec 31, 2021 28,873.40
Jun 30, 2021 36,709.30
Dec 31, 2020 5,912.53
Jun 30, 2020 27,778.04
Dec 31, 2019 32,731.58
Jun 30, 2019 24,499.72
Dec 31, 2018 0.93
Jun 30, 2018 693.45
Dec 31, 2017 480.65
Jun 30, 2017 0.30
Dec 31, 2016 347.32
Jun 30, 2016 0.37